arrow
P

Piergiorgio Solli

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:37
被引数:7,906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes and Prognostic Factors in Primary Thoracic Malignant Peripheral Nerve Sheath Tumours: A Multicentre Study

原发性胸廓恶性周围神经鞘瘤的结局与预后因素:一项多中心研究

2026-10-080
PRE
A Chronobiological Prognostic Model for Resected Stage I Non-Small-Cell Lung Cancer

基于昼夜节律的预后模型用于切除的I期非小细胞肺癌

Cancers
IF4.4
2026-10-050
OA
Functional Recovery as a Survivorship Endpoint in Early-Stage NSCLC

早期非小细胞肺癌中功能性恢复作为生存结局指标

Cancers
IF4.4
2026-06-170
OA
International Consensus on Severe Lung Cancer-The Second Edition

国际重症肺癌共识(第二版)

2026-04-300
PRE
Lung Multidisciplinary Team Decision-Making Challenges in Perioperative NSCLC: Borderline Resectability and Discordant Responses Through the Lens of Real-World Scenarios

肺癌多学科团队围手术期决策挑战:通过真实世界场景观察的可切除性边缘病例与意见不一致的应对

Cancers
IF4.4
2026-01-010
OA
Oncological and Surgical Outcomes of Left Trisegmentectomy or Lingulectomy Versus Upper Lobectomy for Early-Stage Non-Small Cell Lung Cancer: A Multicentre Study
2025-12-010
OA
The outcomes of salvage surgery for non-small cell lung cancer after immune checkpoint inhibitor or targeted therapy treatment. A multi-center international real-life study

免疫检查点抑制剂或靶向治疗后非小细胞肺癌挽救性手术的结果。多中心国际现实生活研究

EJSO
IF2.9
2025-06-010
PRE
[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
2024-11-012
OAAI
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study
2024-08-220
OAAI